Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Marina Neyssa M.; Smeland Sigbjorn; Bielack Stefan S.; Bernstein Mark; Jovic Gordana; Krailo Mark D.; Hook Jane M.; Arndt Carola; van den Berg Henk; Brennan Bernadette; Brichard Benedicte; Brown Ken L. B.; Butterfass-Bahloul Trude; Calaminus Gabriele; Daldrup-Link Heike E.; Eriksson Mikael; Gebhardt Mark C.; Gelderblom Hans; Gerss Joachim; Goldsby Robert; Goorin Allen; Gorlick Richard; Grier Holcombe E.; Hale Juliet P.; Hall Kirsten Sundby; Hardes Jendrik; Hawkins Douglas S.; Helmke Knut; Hogendoorn Pancras C. W.; Isakoff Michael S.; Janeway Katherine A.; Juergens Heribert; Kager Leo; Kuhne Thomas; Lau Ching C.; Leavey Patrick J.; Lessnick Stephen L.; Mascarenhas Leo; Meyers Paul A.; Mottl Hubert; Nathrath Michaela; Papai Zsuzsanna; Randall R. Lor; Reichardt Peter; Renard Marleen; Safwat Akmal Ahmed; Schwartz Cindy L.; Stevens Michael C. G.; Strauss Sandra J.; Teot Lisa; Werner Mathias; Sydes Matthew R.; Whelan Jeremy S.

首页> 外文期刊>The lancet oncology >Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

【24h】

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

机译：MAPIE与MAP在新诊断的高度恶性骨肉瘤（EURAMOS-1）对术前化疗反应较差的患者中的比较：一项开放标签，国际，随机对照试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background We designed the EURAMOS-1 trial to investigate whether intensified postoperative chemotherapy for patients whose tumour showed a poor response to preoperative chemotherapy (>= 10% viable tumour) improved event-free survival in patients with high-grade osteosarcoma.

机译：背景我们设计了EURAMOS-1试验，以研究肿瘤对术前化疗反应不良（> = 10％活肿瘤）的患者加强术后化疗能否改善高级别骨肉瘤患者的无事件生存率。

著录项

来源
《The lancet oncology》 |2016年第10期|共13页
作者
Marina Neyssa M.; Smeland Sigbjorn; Bielack Stefan S.; Bernstein Mark; Jovic Gordana; Krailo Mark D.; Hook Jane M.; Arndt Carola; van den Berg Henk; Brennan Bernadette; Brichard Benedicte; Brown Ken L. B.; Butterfass-Bahloul Trude; Calaminus Gabriele; Daldrup-Link Heike E.; Eriksson Mikael; Gebhardt Mark C.; Gelderblom Hans; Gerss Joachim; Goldsby Robert; Goorin Allen; Gorlick Richard; Grier Holcombe E.; Hale Juliet P.; Hall Kirsten Sundby; Hardes Jendrik; Hawkins Douglas S.; Helmke Knut; Hogendoorn Pancras C. W.; Isakoff Michael S.; Janeway Katherine A.; Juergens Heribert; Kager Leo; Kuhne Thomas; Lau Ching C.; Leavey Patrick J.; Lessnick Stephen L.; Mascarenhas Leo; Meyers Paul A.; Mottl Hubert; Nathrath Michaela; Papai Zsuzsanna; Randall R. Lor; Reichardt Peter; Renard Marleen; Safwat Akmal Ahmed; Schwartz Cindy L.; Stevens Michael C. G.; Strauss Sandra J.; Teot Lisa; Werner Mathias; Sydes Matthew R.; Whelan Jeremy S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial [J] . Marina Neyssa M., Smeland Sigbjorn, Bielack Stefan S., The lancet oncology . 2016,第10期

机译：MAPIE与MAP在新诊断的高度恶性骨肉瘤（EURAMOS-1）对术前化疗反应较差的患者中的比较：一项开放标签，国际，随机对照试验
2. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial (vol 33, pg 2279, 2015) [J] . Bielack Journal of Clinical Oncology . 2016,第33期

机译：甲氨蝶呤，阿霉素和顺铂（MAP）加上可维护的聚乙二醇化干扰素Alfa-2b与MAP单独治疗可切除的高度骨肉瘤且对术前MAP的组织学反应良好：EURAMOS-1良好治疗随机对照试验的第一个结果（第33卷），第2279页，2015年）
3. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial [J] . Bielack Stefan S., Smeland Sigbjorn, Whelan Jeremy S., Journal of Clinical Oncology . 2015,第20期

机译：甲氨蝶呤，阿霉素和顺铂（MAP）加上可维护的聚乙二醇化干扰素Alfa-2b与MAP单独治疗可切除的高级别骨肉瘤和术前MAP的组织学响应良好：EURAMOS-1的第一结果良好响应随机对照试验
4. The effect of Virtual Reality in reducing preoperative anxiety in patients prior to arthroscopic knee surgery: A randomised controlled trial [C] . Anitra Robertson, Riaz Khan, Daniel Fick, IEEE International Conference on Serious Games and Applications for Health . 2017

机译：虚拟现实在关节镜膝关节手术前降低患者术前焦虑的作用：一项随机对照试验
5. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label international randomised controlled trial [O] . Neyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, -1

机译：新诊断的高度骨肉瘤（EURAMOS-1）对术前化疗反应不良的患者中MAPIE与MAP的比较：一项开放性国际性随机对照试验
6. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial [O] . Marina, Neyssa M., Smeland, Sigbjørn, Bielack, Stefan S., 2016

机译：MAPIE与MAP在新诊断的高级别骨肉瘤（EURAMOS-1）对术前化疗反应不良的患者中的比较：一项开放性，国际性，随机对照试验

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

摘要

著录项

相似文献

相关主题

期刊订阅